Cline Christopher R. sold TVTX
April 14, 2026 · Form 4 insider transaction
Cline Christopher R. sold 9 shares of Travere Therapeutics, Inc. at $41.07 per share, a transaction worth $369.63. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
9
Price
$41.07
Total value
$369.63
InsiderCline Christopher R.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 14, 2026
Filing dateApril 15, 2026
Shares owned after125,152
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.